Karyopharm Therapeutics
KPTI
$1.10
Share price
3.77%
Change (1 day)
-71.43%
Change (1 year)
Categories
Karyopharm Therapeutics (KPTI) Fails to deliver data
Key failure to deliver metrics for Karyopharm Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.32 M
- Last 3 months FTD volume: $0.72 M
- Last year FTD volume: $36.52 M
Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2013
Volume in USD (price x number of shares), data since 2013Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.72 M | -98.67% |
| 2023 | $54.81 M | 18.97% |
| 2022 | $46.07 M | 5.78% |
| 2021 | $43.55 M | 77.73% |
| 2020 | $24.5 M | 33.34% |
| 2019 | $18.38 M | 106.04% |
| 2018 | $8.92 M | -65.24% |
| 2017 | $25.66 M | 334.29% |
| 2016 | $5.9 M | -84.55% |
| 2015 | $38.24 M | -42.24% |
| 2014 | $66.21 M | 11206.31% |
| 2013 | $0.58 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $62.08 M | $0.14 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 Exelixis EXEL | $0.65 M | $6.15 M | 🇺🇸 USA |